Unknown NA INTERVENTIONAL 4-arm NCT02114645

The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

To Evaluate the Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes in Both GnRH Agonist and GnRH Antagonist Treated Ovarian Stimulation Protocols

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital

Conditions Infertility

Interventions 4 mg oral estradiol valerate Leuprolide acetate vaginal progesterone

Updated 6 times since 2017 Last updated: Apr 13, 2014 Started: Apr 30, 2014 Primary completion: Feb 28, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02114645, this NA trial focuses on Infertility and remains ongoing. Sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zekai Tahir Burak Women's Health Research and Education Hospital

Data source: Zekai Tahir Burak Women's Health Research and Education Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)